Serial and quantitative analysis of mixed hematopoietic chimerism in patients with acute leukemias allows the prediction of relapse after allogeneic BMT and offers a rational basis for early intervention by additional immunotherapy to prevent hematologic relapse.

被引：0
|
作者：
Bader, P
Schlegel, PG
Frey, A
Beck, J
Hebarth, H
Handgretinger, R
Einsele, H
Niemeyer, C
Benda, N
Faul, C
Kanz, L
Niethammer, D
Klingebiel, T
机构：
[1] UNIV TUBINGEN,DEPT PEDIAT HEMATOL ONCOL,CHILDRENS HOSP,D-72070 TUBINGEN,GERMANY
[2] UNIV TUBINGEN,MED CTR,DEPT HEMATOL ONCOL,D-72070 TUBINGEN,GERMANY
[3] UNIV FREIBURG,CHILDRENS HOSP,DEPT PEDIAT,FREIBURG,GERMANY
[4] DEPT BIOMED STAT,TUBINGEN,GERMANY
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2432 / 2432
页数：1
相关论文
共 15 条
  • [1] Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT
    P Bader
    J Beck
    A Frey
    PG Schlegel
    H Hebarth
    R Handgretinger
    H Einsele
    C Niemeyer
    N Benda
    C Faul
    L Kanz
    D Niethammer
    T Klingebiel
    Bone Marrow Transplantation, 1998, 21 : 487 - 495
  • [2] Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT
    Bader, P
    Beck, J
    Frey, A
    Schlegel, PG
    Hebarth, H
    Handgretinger, R
    Einsele, H
    Niemeyer, C
    Benda, N
    Faul, C
    Kanz, L
    Niethammer, D
    Klingebiel, T
    BONE MARROW TRANSPLANTATION, 1998, 21 (05) : 487 - 495
  • [3] The serial and quantitative analysis of mixed hematopoietic chimerism in patients with acute leukemias allows the prediction of relapse after allogeneic SCT.
    Bader, P
    Beck, J
    Schlegel, PG
    Frey, A
    Hebart, H
    Handgretinger, R
    Einsele, H
    Lang, P
    Niemeyer, C
    Faul, C
    Kanz, L
    Niethammer, D
    Klingebiel, T
    BONE MARROW TRANSPLANTATION, 1998, 21 : S185 - S185
  • [4] Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic BMT in children with acute leukemia: Is there an option to prevent relapse?
    Bader, P
    Beck, J
    Schlegel, PG
    Handgretinger, R
    Niethammer, D
    Klingebiel, T
    BONE MARROW TRANSPLANTATION, 1997, 20 (01) : 79 - 81
  • [5] Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic BMT in children with acute leukemia: is there an option to prevent relapse?
    P Bader
    J Beck
    PG Schlegel
    R Handgretinger
    D Niethammer
    T Klingebiel
    Bone Marrow Transplantation, 1997, 20 : 79 - 81
  • [6] Early immunotherapy on the basis of increasing mixed chimerism - An option to prevent relapse in children with acute leukemias.
    Bader, P
    Schaudt, A
    Beck, JE
    Schlegel, PG
    Handgretinger, R
    Niemeyer, C
    Greil, J
    Kremens, B
    Zintl, F
    Niethammer, D
    Klingebiel, T
    BLOOD, 2000, 96 (11) : 204A - 204A
  • [7] Is there an option to prevent relapse by immunotherapy on the basis of increasing mixed hematopoietic chimerism after allo-SCT in children with acute leukemias?
    Bader, P
    Beck, J
    Schlegel, PG
    Lang, P
    Handgretinger, R
    Niemeyer, C
    Niethammer, D
    Klingebiel, T
    BONE MARROW TRANSPLANTATION, 1998, 21 : S224 - S224
  • [8] Minimal residual disease (MRD) assessment after allogeneic BMT for childhood acute lymphoblastic leukaemia (ALL) allows early prediction of relapse.
    Knechtli, C
    Goulden, N
    Harris, E
    Hancock, J
    Jones, C
    Grandage, V
    Garland, R
    Potter, M
    Cornish, J
    Pamphilon, D
    Steward, C
    Oakhill, A
    BLOOD, 1997, 90 (10) : 2431 - 2431
  • [9] Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children
    P Bader
    T Klingebiel
    A Schaudt
    U Theurer-Mainka
    R Handgretinger
    P Lang
    D Niethammer
    JF Beck
    Leukemia, 1999, 13 : 2079 - 2086
  • [10] Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children
    Bader, P
    Klingebiel, T
    Schaudt, A
    Theurer-Mainka, U
    Handgretinger, R
    Lang, P
    Niethammer, D
    Beck, JF
    LEUKEMIA, 1999, 13 (12) : 2079 - 2086
12